Researchers at IRB Barcelona discover a new mechanism in estrogen receptor-positive breast cancer cells.
The inhibition of CPEB2, a key factor in the estrogen signalling pathway, causes cancer cells to proliferate less and protects mice against luminal breast cancer.
The foundation will be funding 43 cancer research projects.
On 16 September, the ”la Caixa” Foundation presented the 79 grants for national and international research and innovation projects of excellence—among these four projects from the Institute for Research in Biomedicine (IRB Barcelona).
Among the beneficiaries of funding from ”la Caixa”, IRB Barcelona researchers Eduard Batlle and Raúl Méndez obtained two grants from the call for research projects in biomedicine and health, Meritxel Teixidó received a grant from the CaixaImpulse Programme, and Enrique Marcos was awarded a postdoctoral fellowship.
Characterised by a central theme “Questions for the future”,...
La Vanguardia newspaper has interviewed Raúl Méndez, a researcher at IRB Barcelona, and José J. Lucas, from the Severo Ochoa Molecular Biology Center of the CSIC, about the study related to autism and that iscompeting for the Vanguardia de la Ciencia prize: "The fact that there are environmental factors involved in autism does not mean that vaccines are one of these environmental factors. The alleged relation between childhood vaccination and autism has no basis. CPEB4 influences the development of the nervous system especially during the prenatal stage, and children do not receive vaccines before they are born, "said Raúl Méndez.
The Barcelona Institute of Science and Technology (BIST) will be bringing together 100 female researchers and technologists in a training and networking session next Thursday, 7 February, at the Barcelona Science Park. IRB Barcelona will be participating in this event.
The gathering is devoted to the preparation of the talks that the scientists will be giving around Catalonia on the International Day of Women and Girls in Science (11 February) and to ‘fostering a sense of community’ to reinforce the role of women as scientific and social leaders.
The mayor of Barcelona, Ada Colau, will be opening the event, which forms part of the Biennial City and Science Programme.
The research focuses on the CPEB4 protein, a key molecule in the development of this neurological disorder.
The award is a joint initiative of La Vanguardia and the Fundació Catalunya-La Pedrera.
La Vanguardia has published an article about a research project led by IRB Barcelona and the Severo Ochoa Molecular Biology Centre that has been nominated for the "Vanguardia de la Ciencia" Award. Addressing the CPEB4 protein, the study reveals that it is a key factor in the origin of autism. The winning project will be chosen through a popular vote. The last day to vote is 28 February.
Link to La Vanguardia
From 7 to 11 February, the general public will have the opportunity to participate in activities related to ageing, nanoscience and climate change, among others.
IRB Barcelona will be taking part in the Biennal event through three initiatives that target the public.
El Independiente, Catalunya Ràdio and La Vanguardia have interviewed Raúl Méndez, ICREA researcher at IRB Barcelona, to learn more about the recently published study on autism. Méndez points out that despite the importance of the discovery, "we are 'far away' from achieving a cure or solution to the autism spectrum disorder, although it will allow us to focus future studies in this direction."
Link to El Independiente
RTVE, Ara, 20 Minutos, Daily Mail, Jornal Médico, Sic Noticias, among other national and international media, have published articles about a recent study on autism. Researchers co-led by Raúl Méndez, head of the Translational Control of Cell Cycle and Differentiation Lab at IRB Barcelona, have discovered that the protein CPEB4, a molecule that regulates protein synthesis, is impaired in most cases of autism.
Link to RTVE